TipRanks
Go Ultimate55% OFF

Acurx Pharmaceuticals (3ZO0) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

3ZO0 Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Acurx Pharmaceuticals in the past 3 months

3ZO0 Stock 12 Month Forecast

EUR 15.25▲(199.51% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Acurx Pharmaceuticals in the last 3 months. The average price target is EUR 15.25 with a high forecast of EUR 27.80 and a low forecast of EUR 8.97. The average price target represents a 199.51% change from the last price of EUR 5.09.
Highest Price TargetEUR 27.80Average Price TargetEUR 15.25Lowest Price TargetEUR 8.97

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:3ZO0
Price TargetFollowArticle
H.C. WainwrightEUR 27.80buy446.17%UpsideReiterated09/29/26
Alliance Global PartnersEUR 8.97buy76.18%UpsideReiterated09/29/26
Maxim GroupEUR 8.97buy76.18%UpsideReiterated08/17/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Acurx Pharmaceuticals

3 Months
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate1/9 ratings generated profit
11%
Average Return
-26.90%

Copying Matthew Keller's trades and holding each position for 3 Months would result in 11.11% of your transactions generating a profit, with an average return of -26.90% per trade.

1 Year
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate0/9 ratings generated profit
0%
Average Return
-56.06%

Copying Matthew Keller's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -56.06% per trade.

2 Years
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate0/9 ratings generated profit
0%
Average Return
-59.26%

Copying Matthew Keller's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -59.26% per trade.

3ZO0 Analyst Recommendation Trends

05101520Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 3ZO0
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy44355
Buy00000
Hold00000
Sell00000
Strong Sell00000
total44355

In the current month, 3ZO0 has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 3ZO0 average Analyst price target in the past 3 months is 15.25.

3ZO0 Financial Forecast

EUR -3EUR -2.25EUR -1.5EUR -0.75EUR 0Q4 2025Q2 2026Q3 2026
HighEUR -0.25
ConsensusEUR -0.34
LowEUR -0.40

3ZO0 Earnings Forecast

Next quarter’s earnings estimate for 3ZO0 is -EUR 0.34 with a range of -EUR 0.40 to -EUR 0.25. The previous quarter’s EPS was -EUR 0.47. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR -1EUR -0.5EUR 0EUR 0.5EUR 1Q4 2025Q2 2026Q3 2026
HighEUR 0.00
ConsensusEUR 0.00
LowEUR 0.00

3ZO0 Sales Forecast

Next quarter’s sales forecast for 3ZO0 is EUR 0 with a range of EUR 0 to EUR 0. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

3ZO0 Stock Forecast FAQ

What is DE:3ZO0’s average 12-month price target, according to analysts?
Based on analyst ratings, Acurx Pharmaceuticals’s 12-month average price target is €15.25.
What is DE:3ZO0’s upside potential, based on the analysts’ average price target?
Acurx Pharmaceuticals has 199.51% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Acurx Pharmaceuticals a Buy, Sell or Hold?
Acurx Pharmaceuticals has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Acurx Pharmaceuticals’s share price target?
The average share price target for Acurx Pharmaceuticals is €15.25. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €27.80, and the lowest forecast is €8.97. The average share price target represents a 199.51% increase from the current price of €5.09.
What do analysts say about Acurx Pharmaceuticals?
Acurx Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Acurx Pharmaceuticals?
To buy shares of DE:3ZO0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.